- Home
- PRTA vs SPTN Comparison
PRTA vs SPTN Comparison
Compare PRTA & SPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- SPTN
- Stock Information
- Founded
- PRTA 2012
- SPTN 1917
- Country
- PRTA Ireland
- SPTN United States
- Employees
- PRTA N/A
- SPTN N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- SPTN Food Distributors
- Sector
- PRTA Health Care
- SPTN Consumer Discretionary
- Exchange
- PRTA Nasdaq
- SPTN Nasdaq
- Market Cap
- PRTA 809.8M
- SPTN 654.2M
- IPO Year
- PRTA N/A
- SPTN N/A
- Fundamental
- Price
- PRTA $7.18
- SPTN $19.84
- Analyst Decision
- PRTA Buy
- SPTN Hold
- Analyst Count
- PRTA 9
- SPTN 1
- Target Price
- PRTA $51.71
- SPTN $20.00
- AVG Volume (30 Days)
- PRTA 1.6M
- SPTN 269.9K
- Earning Date
- PRTA 05-08-2025
- SPTN 05-29-2025
- Dividend Yield
- PRTA N/A
- SPTN 4.41%
- EPS Growth
- PRTA N/A
- SPTN N/A
- EPS
- PRTA N/A
- SPTN 0.01
- Revenue
- PRTA $137,935,000.00
- SPTN $9,549,324,000.00
- Revenue This Year
- PRTA N/A
- SPTN $5.82
- Revenue Next Year
- PRTA $122.59
- SPTN N/A
- P/E Ratio
- PRTA N/A
- SPTN $2,255.00
- Revenue Growth
- PRTA 54.55
- SPTN N/A
- 52 Week Low
- PRTA $8.00
- SPTN $17.30
- 52 Week High
- PRTA $25.42
- SPTN $23.00
- Technical
- Relative Strength Index (RSI)
- PRTA 30.36
- SPTN 54.69
- Support Level
- PRTA $6.47
- SPTN $18.51
- Resistance Level
- PRTA $8.08
- SPTN $19.39
- Average True Range (ATR)
- PRTA 0.72
- SPTN 0.47
- MACD
- PRTA 0.00
- SPTN 0.01
- Stochastic Oscillator
- PRTA 21.60
- SPTN 77.33
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
About SPTN SpartanNash Company
SpartanNash Co is a food solutions company that delivers the ingredients. Its principal business activities include, distributing grocery products to a diverse group of independent and chain retailers, its corporate-owned retail stores, and U.S. military commissaries and exchanges; as well as operating a fresh produce distribution network and the Our Family private label brand. The company operates in two segments: Retail and Wholesale. Majority of the revenue is earned from its Wholesale segment which uses a multi-channel sales approach to distribute national brand and private brand products to independent retailers, national accounts, food service distributors, e-commerce providers, and the Company's corporate owned retail stores.